We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Quotient Becomes European Center for Clinical Laboratory Testing Services

By LabMedica International staff writers
Posted on 01 Sep 2009
Quotient Bioresearch Ltd. More...
(Fordham, UK) and Clinical Reference Laboratory Global Services (CRL; Lenexa, KS, USA) have concluded an agreement that will result in joint clinical laboratory and other specialist testing services.

CRL Global Services will set up its European clinical reference laboratory operation within Quotient's state-of-the-art facility in Cambridgeshire, UK, establishing it as the European focus for its central laboratory services unit. This will complement Quotient's existing clinical laboratory services, particularly in the area of bioanalysis and biomarkers.

The services of the two organizations are entirely complementary, creating considerable benefits for clients from the combined offering of the two groups. Paul Cowan, CEO of Quotient Bioresearch commented: "This collaboration brings exciting new opportunities for our bioanalytical sciences and microbiology businesses. Working in tandem with CRL offers access to a well established, standardized global laboratory infrastructure and the ability to serve the requirements of our clients for global clinical trials.”

Related Links:

Quotient Bioresearch
Clinical Reference Laboratory Global Services



New
Gold Member
Aspiration System
VACUSAFE
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
POC Immunoassay Analyzer
Procise DX
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.